[1]
“Genetic Variation in CYP2D6 and Adverse Effects in Cardiovascular Patients on Metoprolol Therapy”, Precis. Med. Com., vol. 4, no. 1, pp. 41–49, Jun. 2024, doi: 10.55627/pmc.004.001.0776.